CATTALINI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 5.208
EU - Europa 3.788
AS - Asia 3.078
SA - Sud America 803
AF - Africa 65
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
Totale 12.958
Nazione #
US - Stati Uniti d'America 5.125
PL - Polonia 1.605
SG - Singapore 1.133
CN - Cina 788
BR - Brasile 681
UA - Ucraina 466
HK - Hong Kong 460
DE - Germania 367
FR - Francia 347
IT - Italia 292
VN - Vietnam 281
FI - Finlandia 169
GB - Regno Unito 159
RU - Federazione Russa 141
TR - Turchia 133
IE - Irlanda 105
ID - Indonesia 60
IN - India 54
AR - Argentina 41
BD - Bangladesh 39
CA - Canada 36
MX - Messico 30
EC - Ecuador 27
SE - Svezia 24
BE - Belgio 23
ZA - Sudafrica 21
ES - Italia 19
JP - Giappone 19
NL - Olanda 19
IQ - Iraq 18
AT - Austria 16
CO - Colombia 16
PK - Pakistan 14
MA - Marocco 13
SA - Arabia Saudita 12
CZ - Repubblica Ceca 10
AU - Australia 8
PE - Perù 8
VE - Venezuela 8
EG - Egitto 7
KE - Kenya 7
PY - Paraguay 7
UZ - Uzbekistan 7
CH - Svizzera 6
IL - Israele 6
UY - Uruguay 6
CL - Cile 5
DZ - Algeria 5
EU - Europa 5
HN - Honduras 5
KG - Kirghizistan 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
IR - Iran 4
JO - Giordania 4
LT - Lituania 4
PH - Filippine 4
TH - Thailandia 4
AM - Armenia 3
AZ - Azerbaigian 3
BO - Bolivia 3
LB - Libano 3
NP - Nepal 3
SN - Senegal 3
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
JM - Giamaica 2
KH - Cambogia 2
KZ - Kazakistan 2
MY - Malesia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
PT - Portogallo 2
QA - Qatar 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DM - Dominica 1
FK - Isole Falkland (Malvinas) 1
GI - Gibilterra 1
HU - Ungheria 1
IM - Isola di Man 1
KR - Corea 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
MM - Myanmar 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
Totale 12.956
Città #
Warsaw 1.604
Fairfield 628
Woodbridge 514
Singapore 502
Hong Kong 458
Ashburn 453
Jacksonville 355
Houston 344
Seattle 243
Beijing 235
Cambridge 224
Wilmington 218
Ann Arbor 206
Chandler 186
Princeton 165
New York 150
Istanbul 115
Los Angeles 109
Dublin 105
Helsinki 97
Nanjing 87
Ho Chi Minh City 86
Munich 80
Dong Ket 70
The Dalles 64
Des Moines 63
Brescia 62
São Paulo 59
Redondo Beach 54
Moscow 49
Chicago 43
Shenyang 42
San Francisco 41
Jakarta 39
Nanchang 38
Shanghai 38
San Diego 36
Buffalo 35
Hanoi 35
Milan 34
Dallas 33
Dearborn 25
Changsha 24
Lancaster 23
Turku 23
Hebei 22
London 22
Rio de Janeiro 21
Santa Clara 21
Tianjin 21
Brussels 20
Jinan 19
Phoenix 19
Boardman 18
Lappeenranta 18
Nuremberg 18
Denver 16
Romola 15
Tokyo 15
Assemini 14
Belo Horizonte 14
Ningbo 14
Poplar 14
Toronto 13
Zhengzhou 13
Atlanta 12
Frankfurt am Main 12
Rome 12
Guangzhou 11
Johannesburg 11
Orem 11
Stockholm 11
Brasília 10
Chennai 10
Goiânia 10
Montreal 10
Porto Alegre 10
Brooklyn 9
Campinas 9
Düsseldorf 9
Mexico City 9
Quito 9
Salt Lake City 9
Salvador 9
Bogotá 8
Boston 8
Dhaka 8
Guarulhos 8
Haiphong 8
Paris 8
Santo André 8
Trieste 8
Verona 8
Curitiba 7
Da Nang 7
Guayaquil 7
Haikou 7
Hyderabad 7
Jiaxing 7
Kunming 7
Totale 8.755
Nome #
Basic Characteristics of Adults with Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenopathy Syndrome in Comparison with the Typical Pediatric Expression of Disease 301
Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): An open-label, phase II study 300
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 284
The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry 280
Developing a Predictive Score for Chronic Arthritis among a Cohort of Children with Musculoskeletal Complaints - The Chronic Arthritis Score Study 269
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept 262
Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: A case series 247
Interleukin-1: Ariadne's Thread in Autoinflammatory and Autoimmune Disorders 235
When flexibility is not necessarily a virtue: a review of hypermobility syndromes and chronic or recurrent musculoskeletal pain in children 229
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis 228
A national cohort study on pediatric Behçet's disease: Cross-sectional data from an Italian registry 223
Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? 212
Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis 211
Canakinumab for the treatment of autoinflammatory recurrent fever syndromes 186
Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation. 172
Allele *1 of HS1.2 enhancer associates with selective IgA deficiency and IgM concentration. 160
IPSC-DERIVED NEURONS AS AN IN VITRO MODEL FOR THE STUDY OF INTERFERONOPATHIES WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT 156
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 155
Clinical and Laboratory Features of 184 Italian Pediatric Patients Affected with Selective IgA Deficiency (SIgAD): a Longitudinal Single-Center Study 153
The change in Ig regulation from children to adults disconnects the correlation with the 3'RR hs1.2 polymorphism 152
Autosomal recessive agammaglobulinemia: novel insights from mutations in Ig-beta 151
Body experiences, emotional competence, and psychosocial functioning in juvenile idiopathic arthritis. 150
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 148
DISCRIMINATION AMONG MONOGENIC AND ACQUIRED DISEASE WITH INFLAMMATORY AND AUTOIMMUNE COMPONENT THROUGH THE IN VITRO STUDY OF SIGNAL TRANSDUCERS OF TYPE I INTERFERON 145
The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry 143
Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children 142
Profound T-cell defects in Dubowitz syndrome 141
Development of the autoinflammatory disease damage index (ADDI) 139
In silico validation of the autoinflammatory disease damage index 139
Aicardi Goutieres Syndrome: New Insights on a Novel Set of Inborn Errors of Immunity 134
Exploring Autoimmunity in a Cohort of Children with Genetically Confirmed Aicardi–Goutières Syndrome 133
Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome 128
Chronic nonbacterial osteomyelitis may be associated with renal disease and bisphosphonates are a good option for the majority of patients 127
Condylar asymmetry in patients with juvenile idiopathic arthritis: Could it be a sign of a possible temporomandibular joints involvement? 126
Cryopyrin-associated periodic syndromes in Italian Patients: Evaluation of the rate of somatic NLRP3 mosaicism and phenotypic characterization 123
The multifaceted presentation of chronic recurrent multifocal osteomyelitis: A series of 486 cases from the Eurofever international registry 123
Establishment of three iPSC lines from fibroblasts of a patient with Aicardi Goutières syndrome mutated in RNaseH2B 122
Cooperative intervention to assist children with HIV-infection in Burkina Faso: The Brescia experience during the pilot phase of the ESTHER Project. 121
Differential impact of high and low penetrance TNFRSF1A gene mutations on conventional and regulatory CD4+ T cell functions in TNFR1-associated periodic syndrome 121
Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with Anakinra 120
Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis 120
Generation of three isogenic induced Pluripotent Stem Cell lines (iPSCs) from fibroblasts of a patient with Aicardi Goutières Syndrome carrying a c.2471G>A dominant mutation in IFIH1 gene 120
Mutations of the X-linked lymphoproliferative disease gene SH2D1A mimicking common variable immunodeficiency. 117
Sex Differences in Pediatric Rheumatology 117
Anakinra drug retention rate and predictive factors of long-term response in systemic juvenile idiopathic arthritis and adult onset still disease 117
Differentiating PFAPA syndrome from monogenic periodic fevers. 113
Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils. 112
Musculoskeletal pain in children, when hypermobility is the problem 110
Recurrent migratory angioedema as cutaneous manifestation in a familiar case of TRAPS: dramatic response to Anakinra 109
Systemic and organ involvement in monogenic autoinflammatory disorders: a global review filtered through internists’ lens 109
Generation of three iPSC lines from fibroblasts of a patient with Aicardi Goutières Syndrome mutated in TREX1 109
Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene. 108
Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: Analysis by the Pharmachild Safety Adjudication Committee 107
Overview of fever of unknown origin in adult and paediatric patients 98
Serum amyloid protein A concentration in cryopyrin-associated periodic syndromes patients treated with interleukin-1 beta antagonist 95
Contraception in adolescents with systemic lupus erythematosus 92
Clinical impact of MEFV mutations in children with periodic fever in a prevalent western European Caucasian population. 91
Dysregulation of the immune system in Aicardi-Goutières syndrome: another example in a TREX1-mutated patient 89
Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis 88
Prevention of Flare Recurrences in Childhood-Refractory Chronic Uveitis: An Open-LabelComparative Study of Adalimumab Versus Infliximab 84
Development and implementation of the AIDA International Registry for patients with Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis syndrome 83
Favourable and sustained response to anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis. 82
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis 82
PFAPA syndrome and Behçet’s disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists 81
Pitfalls of flow cytometric analysis by dihidrorodamyne-123 in the diagnosis of chronic granulomatous disease. 78
Musculoskeletal manifestations in hereditary periodic fever syndromes 77
Intervento di Cooperazione sanitaria per l'assistenza ai bambini affetti da HIV/AIDS in Burkina Faso: l'esperienza della Clinica Pediatrica di Brescia. 76
Pitfalls of flow cytometric analysis by dihydrorodamine-123 in the diagnosis of chronic granulomatous disease 76
Demographic, clinical and therapeutic findings in a monocentric cohort of adult patients with suspected PFAPA syndrome 76
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis 75
Predicting duration of beneficial effect of joint injection among children with chronic arthritis by measuring biomarkers concentration in synovial fluid at the time of injection. 75
Longitudinal Characterization of Immune Response in a Cohort of Children Hospitalized with Multisystem Inflammatory Syndrome 74
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network 71
INSAID Variant Classification and Eurofever Criteria Guide Optimal Treatment Strategy in Patients with TRAPS: Data from the Eurofever Registry 68
Reumatologia per il pediatra. Cap 43 La PFAPA 66
Covid-19 and autoimmunity 66
Prevalence of cranial involvement in a cohort of Italian patients with chronic non-bacterial osteomyelitis 65
Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome 65
Case Report: The JAK-Inhibitor Ruxolitinib Use in Aicardi-Goutieres Syndrome Due to ADAR1 Mutation 65
Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome-Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA Network 64
Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics 64
Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases 64
Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF- α Receptor - Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA Network 64
High prevalence of rare FBLIM1 gene variants in an Italian cohort of patients with Chronic Non-bacterial Osteomyelitis (CNO) 63
Paediatric MAS/HLH caused by a novel monoallelic activating mutation in p110δ 62
iPSC-derived 3d brain organoids cultured in a bioreactor as an in vitro model for the study of microcephaly in Aicardi Goutières syndrome. 61
Inflammatory pathways signal transducers analysis in iPSC-derived neurons and 3D cerebral organoids 61
The Spectrum of Manifestations of Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV2) Infection in Children: What We Can Learn From Multisystem Inflammatory Syndrome in Children (MIS-C) 59
Treatment response to Janus kinase inhibitor in a child affected by Aicardi-Goutières syndrome 59
La PFAPA 59
Pathogenesis of Autoimmune Cytopenias in Inborn Errors of Immunity Revealing Novel Therapeutic Targets 59
iPSC-derived 3d brain organoids cultured in a bioreactor as an in vitro model for the study of microcephaly in Aicardi Goutières syndrome 57
Transitional care of young people with juvenile idiopathic arthritis in Italy: results of a Delphi consensus survey 57
A patient-driven registry on Behçet's disease: the AIDA for patients pilot project 56
Cardiac MRI in midterm follow-up of MISC: a multicenter study 55
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 55
Manuale di pediatria. La pratica clinica. La dermatomiosite Giovanile e il Lupus eritematoso sistemico 55
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease 55
The Role of Biologic Agents in the Management of Pediatric-Onset Noninfectious Posterior Scleritis 52
Early anakinra treatment improves cardiac outcome of multisystem inflammatory syndrome in children, regardless of disease severity 51
Totale 11.829
Categoria #
all - tutte 64.755
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.755


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.064 0 0 0 0 0 181 96 182 171 185 135 114
2021/2022727 64 104 28 55 6 39 29 59 35 86 56 166
2022/2023609 91 6 8 59 50 175 11 53 91 7 29 29
2023/2024867 53 20 92 65 25 150 30 37 250 8 17 120
2024/20252.325 11 28 31 358 241 161 214 106 298 186 385 306
2025/20262.566 416 589 377 730 402 52 0 0 0 0 0 0
Totale 13.212